Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Trevi Therapeutics, Inc. (TRVI)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | S-1/A |
| Revenues | | | | | | 100.0% |
| Cost of goods sold | | | | | | 200.0% |
| Gross profit | | | | | | -100.0% |
| General and administrative | | | | | | 35.1% |
| EBITDA | | | | | | -135.1% |
| Depreciation | | | | | | 0.1% |
| EBIT | | | | | | -135.1% |
| Pre-tax income | | | | | | -211.4% |
| Income taxes | | | | | | -0.4% |
| Net income | | | | | | -211.0% |
|